SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001264124-03-000009
Filing Date
2003-09-26
Accepted
2003-09-26 13:36:29
Documents
1
Period of Report
2003-09-24

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgardoc.html 4  
1 PRIMARY DOCUMENT edgardoc.xml 4 7884
  Complete submission text file 0001264124-03-000009.txt   9829
Mailing Address 9360 TOWNE CENTRE DR SUITE 110 SAN DIEGO CA 92121
Business Address 9360 TOWNE CENTRE DR SUITE 110 SAN DIEGO CA 92121 6195522200
AMYLIN PHARMACEUTICALS INC (Issuer) CIK: 0000881464 (see all company filings)

IRS No.: 330266089 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address AMYLIN PHARMACEUTICALS INC 9373 TOWNE CENTRE DRIVE SAN DIEGO CA 92121
Business Address AMYLIN PHARMACEUTICALS INC 9373 TOWNE CENTRE DRIVE SAN DIEGO CA 92121 8585522200
BROWN MARTIN R (Reporting) CIK: 0001236398 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-19700 | Film No.: 03912008